Septest Limited has raised $1.5M in seed funding. The company, founded by a sepsis survivor and diagnostic expert, is focused on improving outcomes for sepsis patients.
Septest aims to transform the journey of sepsis patients worldwide, drawing on the firsthand experience of its founder. The seed capital will support the company's mission to save lives through better diagnostics and patient care.















